Keyphrases
COVID-19
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
92%
Cyclooxygenase-2
91%
Prostacyclin
82%
Cyclooxygenase-1 (COX-1)
69%
Peroxisome Proliferator-activated Receptor
67%
Thyroid Hormone Receptor
65%
Endothelium
63%
S100P
61%
Nuclear Receptor
56%
Celecoxib
52%
Diclofenac
51%
Pulmonary Artery
50%
Nitric Oxide
50%
GW0742
49%
Online Self
46%
Self-marking
46%
Endothelium-dependent Vasodilation
46%
PPAR Agonists
46%
Toll-like
46%
Pancreatic Cancer
46%
Coursework
46%
Inflammation
43%
Vasodilation
43%
P2X Receptors
38%
Mortality Prediction
37%
Worksheet
37%
Diabetes
36%
Receptor Antagonist
34%
New Therapies
32%
Endothelium-derived Hyperpolarizing Factor
32%
Pharmacology
32%
Mesenteric Artery
31%
Naproxen
31%
Receptor for Advanced Glycation End Products
30%
Rat Aorta
30%
β-antagonist
30%
Computational Chemistry
30%
Transrepression
30%
First Year
27%
Dilators
27%
E-learning Tools
27%
Acetylcholine
27%
Science Learning
25%
Pulmonary Hypertension
25%
Vascular Dysfunction
25%
Retrospective Cohort Study
24%
Vascular Function
24%
Aspirin
23%
Electronic Learning
22%
Pharmacology, Toxicology and Pharmaceutical Science
Non-Steroidal Anti-Inflammatory Drug
86%
Nitric Oxide
61%
Pancreas Cancer
61%
Celecoxib
53%
Cell Nucleus Receptor
53%
Diclofenac
51%
Prostacyclin
51%
Peroxisome Proliferator Activated Receptor Delta
50%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
49%
Inflammation
48%
PPAR Agonist
47%
Side Effect
46%
Peroxisome Proliferator Activated Receptor
44%
Receptor
44%
Cyclooxygenase 2
42%
Disease
41%
Pulmonary Hypertension
41%
Malignant Neoplasm
40%
Thyroid Hormone Receptor
34%
Beta Adrenergic Receptor Blocking Agent
33%
Cyclooxygenase 1
32%
Naproxen
31%
Thyroid Hormone Receptor Beta
31%
Advanced Glycation End Product Receptor
30%
Hormone Receptor Blocking Agent
30%
Toll Like Receptor 4
30%
Diabetes Mellitus
27%
Enzyme-Linked Immunosorbent Assay
26%
Lipopolysaccharide
25%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
23%
Delta Opiate Receptor Agonist
23%
Acetylcholine
23%
Prostaglandin Synthase
22%
Apamin
21%
Thyroid Hormone
20%
Vasodilator Agent
19%
Metastasis
18%
Delta Opiate Receptor Antagonist
17%
IC50
17%
Adenosine Triphosphate
15%
Hypoxia-Induced Pulmonary Hypertension
15%
Charybdotoxin
15%
Cardiovascular Risk
15%
Hyperthyroidism
15%
Heart Ventricle Hypertrophy
15%
Digestant
15%
Spontaneously Hypertensive Rat
15%
Carvedilol
15%
Neuropathy
15%
Potassium Channel
15%
Medicine and Dentistry
Toll Like Receptor 4
46%
COVID-19
46%
Severe Acute Respiratory Syndrome Coronavirus 2
43%
Vasodilatation
40%
Infection
37%
In Vitro
37%
Purinergic P2X Receptor
30%
Pancreas Cancer
30%
Diabetes
30%
Adenosine Triphosphate
30%
Nitric Oxide
30%
Cyclooxygenase 2
26%
Malignant Neoplasm
25%
Smooth Muscle Cell
23%
Acetylcholine
22%
Purinergic P2X1 Receptor
21%
Cardiovascular System
18%
Cell Nucleus Receptor
18%
Logistic Regression Analysis
18%
Apamin
18%
Nonsteroid Antiinflammatory Agent
17%
Retrospective Cohort Study
17%
C Reactive Protein
17%
Lymphocyte
17%
Cell Function
16%
Endothelial Cell
16%
Innate Immunity
16%
Artery
15%
Transfer of Learning
15%
Cyclooxygenase 1
15%
Prostaglandin Synthase
15%
Predictive Modeling
15%
Pancreas Disease
15%
Thorax Radiography
15%
Peroxisome Proliferator Activated Receptor
15%
Lung Slice
15%
Influenza A
15%
Influenza B
15%
Purinergic P2Y Receptor
15%
Digestant
15%
Spontaneously Hypertensive Rat
15%
Carvedilol
15%
Heart Development
15%
Ventricular Hypertrophy
15%
Proteinase Activated Receptor 2
15%
Advanced Glycation End Product Receptor
15%
Notch
15%
Pulse Rate
15%
Methylglyoxal
15%
Endothelium-Derived Hyperpolarizing Factor
15%
